Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Pharmacokinetics of HNC042 in Healthy Chinese Volunteers
NCT04603989Phase 1Completed
- Sponsor
- Guangzhou Henovcom Bioscience Co., Ltd.
- Start
- Aug 2020
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in influenza comparing HNC042 with Placebo (2 arms). Primary endpoints: Number of subjects with abnormal vital signs, Number of subjects with abnormal laboratory values and 5 more. Started Aug 2020; status: completed.
02
Drugs
HNC042
03
Conditions
influenza
Beyond the preview
Go deeper on NCT04603989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04603989.